Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study

Area of Science:

• Neurology
• Immunology
• Clinical Research

Background:

• Refractory chronic inflammatory demyelinating polyneuropathy (CIDP) presents a significant clinical challenge due to poor response to immune therapies and substantial disability.
• A deeper understanding of the clinical profile, electrophysiological characteristics, and risk factors for refractory CIDP is needed.

Purpose of the Study:

• To comprehensively describe the clinical and electrophysiological characteristics of refractory CIDP.
• To identify potential risk factors associated with refractory CIDP.

Main Methods:

• A cross-sectional study utilizing data from the Huashan Peripheral Neuropathy Database (HSPN).
• Patients were classified into refractory and non-refractory CIDP groups based on treatment response.
• Multivariate logistic regression was employed to explore risk factors for refractory CIDP.

Main Results:

• Refractory CIDP patients exhibited longer disease duration (48.96 ± 33.72 months) and worse functional impairment compared to non-refractory patients.
• Electrophysiological studies indicated greater axonal impairment and more severe demyelination in refractory CIDP.
• Longer disease duration was identified as an independent risk factor for refractory CIDP.

Conclusions:

• This study provides a detailed characterization of refractory CIDP, including its clinical course patterns, electrophysiological findings, and prognostic factors.
• The findings enhance the understanding of this challenging CIDP subset and may guide future management and treatment approaches.